Brand collabs often a similar pattern. So it’s remarkable to see Apple modify its logo for each of the 30 Major League Soccer ...

BREYANZI has significant market potential due to its innovative approach as a CD19-directed chimeric antigen receptor (CAR) T-cell therapy. The growing prevalence of hematologic malignancies ...

DelveInsight's 'BREYANZI Market Size, Forecast, and Market Insight Report' highlights the details around BREYANZI, a CD19-directed CAR ...

Proposed transaction is a reverse takeover transaction with 1317220 B.C. Ltd.Concurrent $10 million equity financing brokered by Clarus ...

Researchers from the University of Chicago Medicine Comprehensive Cancer Center demonstrated the potential of a novel treatment approach including immunotherapy to treat advanced human papillomavirus ...

The collaboration has already yielded strong results, including the in-licensing of EVT8683 (now BMS-986419) by Bristol Myers Squibb in September 2021. In March 2023, the companies reaffirmed their ...

Just nine weeks after UnitedHealthcare CEO Brian Thompson was murdered on a weekday morning on a busy street, the luminaries ...

BMS Re, the reinsurance arm of independent re/insurance broker BMS Group, has announced two new senior appointments: Jonathan Hughes as managing director - non-marine reinsurance and Martin Bartell as ...

481 participants were randomised to PBA±BMS (n=160), DCBA±BMS (n=161), or DES (n=160; fig 1). On 12 December 2018, recruitment was stopped by the trial management group, supported by the trial ...

Furthermore, Kinetic Group is advancing technology and localising the BMS under the PLI Schemes initiated by the Prime Minister’s Make in India initiative.